Now, and every quarter, Thomson Scientific takes the pulse of the industry with this lively free review of the latest phase changes in the pharmaceutical pipeline.

In The Ones To Watch you'll get expert insight into the five most promising drugs:

• reaching the market
• entering Phase III trials
• entering Phase II trials
• entering Phase I trials

Why not subscribe below to receive the latest edition of The Ones to Watch and get future editions delivered direct to your desktop, every quarter? Subscription is completely free and without obligation.

The Scientific business of Thomson Reuters would like to keep you up to date with developments to our products and services. We would also like to invite you to special events such as seminars and receptions, and we would like you to benefit from our free newsletters and other resources.

Find out more about brands from the Scientific business of Thomson Reuters.

For information about our privacy policies or to change your communications preferences, please refer to our Privacy Statement.